Trump Psychedelics Executive Order
Key Questions
What is the purpose of President Trump's executive order on psychedelics?
The executive order fast-tracks FDA reviews for ibogaine and MDMA to treat PTSD in veterans. It includes $50 million in state funding and involves RFK Jr. to boost research and counter recent setbacks.
What potential outcomes are expected from this executive order?
The order aims to accelerate psychedelic research for veterans' mental health. Potential FDA approvals for these treatments are projected by 2027.
How have veterans reacted to the executive order?
A Valley veteran has reacted to President Trump's executive order signed over the weekend, which fast-tracks psychedelic research. The response highlights support for advancing treatments for PTSD.
EO fast-tracks FDA reviews for ibogaine/MDMA vets PTSD, $50M states, Right to Try; TX research/red tape cuts, AZ vet reactions mixed on clinical hurdles. Potential 2027 approvals amid implementation.
Sources (1)
Updated Apr 21, 2026